ICU sedation, delirium & recovery

Exploring the association between computed tomography (CT)-derived skeletal muscle mass and short- and long-term mortality in critically ill patients: a systematic review and meta-analysis

Crit CarePublished Systematic review and meta-analysis of observational studies

Pooled result · Short-term mortalityResult — go to the resultOdds ratio 2.33 CI 1.90–2.87

Authors' conclusion

CT-assessed skeletal muscle mass at the lumbar level on admission to ICU is associated with both short- and long-term mortality.

Study context

Population
Critically ill adults (≥ 18 years) in intensive care units (ICU) with CT-derived skeletal muscle mass at the lumbar level within ± 7 days of ICU admission
Participants
9,366 adults · 35 studies
Comparison
Low vs preserved CT-derived skeletal muscle mass
Outcome
Mortality: short-term (ICU, hospital, 28- and 30-day) and long-term (> 30 days)
Methodological detailsPRISMA 2020, prevalence meta-analysis, Mostly retrospective, single-centre studies; heterogeneous populations (sepsis, COVID-19, trauma)
  • PRISMA 2020
  • Prevalence meta-analysis
  • Mostly retrospective, single-centre studies; heterogeneous populations (sepsis, COVID-19, trauma)

Pooled result

Short-term mortality

Odds ratio

2.33

CI 1.90–2.87

Low muscle mass vs Preserved muscle mass
OR 2.33 (CI 1.90–2.87)

As reported in the abstract

Further pooled results

OutcomeOR (CI)
Long-term mortality (> 30 days)I2 = 62.24%2.67 (1.45–4.92)
  • Long-term mortality (> 30 days): evaluated in 11 studies

Overall prevalence of low muscle mass

Prevalence of low muscle mass
42% (CI 34-49%, I2 = 98.2%)

Original publication

Exploring the association between computed tomography (CT)-derived skeletal muscle mass and short- and long-term mortality in critically ill patients: a systematic review and meta-analysis. Crit Care. Published 3 June 2025. doi:10.1186/s13054-025-05427-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.